Cancer Models ForumPosted by Anna, October 2019How organoids could bridge the gap between in vivo and in vitro preclinical cancer models
Cancer Models ForumPosted by Anna, October 2019What’s the hype about organoids? Here’s 3 ways that organoids could boost your drug development programme
Cancer Models ForumPosted by Terence, September 2019How to revamp your high-throughput screening projects
Press ReleasePosted by Repositive, September 2019Repositive appoints Slaven Stekovic as Head of Strategic Growth and leading commercial advisers to drive the company’s scale-up and global growth ambitions
Cancer Models ForumPosted by Ruth, September 20194 promising therapeutic approaches being developed in the fight against cancer
Cancer Models ForumPosted by Arielle, July 2019Key takeaways from the Milner Therapeutics Symposium 2019
Press ReleasePosted by Repositive, July 2019Repositive makes world-leading directory of 5,300 preclinical cancer models publicly browsable as first stage of platform relaunch
Cancer Models ForumPosted by Steven, June 2019How to find the perfect in vivo cancer model with your gene expression signature
Cancer Models ForumPosted by Alicia, May 2019Top tips for reducing the risk of tumour resistance developing to novel cancer therapies
Cancer Models ForumPosted by Repositive, May 2019The 3 most common challenges when searching for preclinical cancer models
